| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |